The Latest Cardiac and Vascular News
May 16, 2024 04:05 PM Eastern Daylight Time BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients […]
Commercialized Products is Allowed to be Sold in Most of the Provinces in China Continue to Grow Sales of a Product Suite of Stroke Thrombectomy Devices HONG KONG, Aug. 31, 2021 /PRNewswire/ — Shanghai HeartCare Medical Technology Corporation Limited (“HeartCare Medical” or the […]
BRISBANE, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced the launch of the Surveillance HeartCare® Outcomes […]
